Searchable abstracts of presentations at key conferences in endocrinology

ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

Endocrine Abstracts

Published by BioScientifica

Previous issue | Volume 11 | ECE2006 | Next issue

8th European Congress of Endocrinology incorporating the British Endocrine Societies

Poster Presentations

Diabetes, metabolism and cardiovascular

Previous section
Cytokines and growth factors

Table of contents

Next section
Endocrine disruptors

ea0011p251 | Diabetes, metabolism and cardiovascular

The involvement of GH-IGF-I axis in a mouse model of type II diabetic nephropathy

ea0011p252 | Diabetes, metabolism and cardiovascular

Sodium bicarbonate reacts with polysaccharides starch to enhance exercise

ea0011p253 | Diabetes, metabolism and cardiovascular

New function for the enzyme amylase discovered: amylase works as a catalyst/hydrolyzing agent to break down, disaccharides (sucrose, lactose, maltose… etc) and polysaccharides (starch)

ea0011p254 | Diabetes, metabolism and cardiovascular

Liver GH receptor signaling in type I diabetic mice

ea0011p255 | Diabetes, metabolism and cardiovascular

The effects of changes in insulin sensitivity on androgen supply values in diabetic men at different age

ea0011p256 | Diabetes, metabolism and cardiovascular

The effect, in clinical practice, of long-acting fluvastatin (LAF) on low density lipoprotein-cholesterol (LDL-Ch) in patients with type 2 diabetes mellitus (T2DM) in which other statins have failed to achieve the goals

ea0011p257 | Diabetes, metabolism and cardiovascular

Nutritional outcome in end-stage renal disease diabetic patients: short term follow-up of patients initiating/escaping dialysis

ea0011p258 | Diabetes, metabolism and cardiovascular

Improvement of nutritional status in non-dialysed uremic diabetic patients

ea0011p259 | Diabetes, metabolism and cardiovascular

Subthalamic nucleus stimulation in parkinsonian patients does not increase serum ghrelin levels

ea0011p260 | Diabetes, metabolism and cardiovascular

Hyperandrogenism as a risk factor of coronary artery disease in young women

ea0011p261 | Diabetes, metabolism and cardiovascular

Comparison of urinary N-Acytyl β-D glucoseaminidase activity in diabetic patients and controls

ea0011p262 | Diabetes, metabolism and cardiovascular

Association of hypogonadism and type 2 diabetes in men attending an outpatient erectile dysfunction clinic

ea0011p263 | Diabetes, metabolism and cardiovascular

Estimation of the lipid metabolism in women with gestational diabetes mellitus (part 2). Differences resulting from the method of treatment

ea0011p264 | Diabetes, metabolism and cardiovascular

Estimation of some parameters of lipid metabolism in pregnant women with gestational diabetes mellitus

ea0011p265 | Diabetes, metabolism and cardiovascular

The role of a lifestyle modification in preventing type II diabetes mellitus in subjects with high-risk factors

ea0011p266 | Diabetes, metabolism and cardiovascular

The effect of Greek mediterranean diet on trace elements and blood coagulation factors in type 2 diabetic patients

ea0011p267 | Diabetes, metabolism and cardiovascular

12 month audit of insulin glargine use in the diabetic clinic

ea0011p268 | Diabetes, metabolism and cardiovascular

Increased expression of the adipokines resistin and fiaf in hypoxic/ischemic mouse brain

ea0011p269 | Diabetes, metabolism and cardiovascular

Prevalence of chronic cardiovascular complications in newly diagnosed type 2 diabetic patients

ea0011p270 | Diabetes, metabolism and cardiovascular

Hormonal profile associated with the insulin sensitive obese subjects

ea0011p271 | Diabetes, metabolism and cardiovascular

AT₁ receptor activation mediated oxidative stress and uncoupling protein-2 driven beta-cell dysfunction in obesity-induced Type 2 diabetes mellitus

ea0011p272 | Diabetes, metabolism and cardiovascular

Effects of hyperglycemia on the AT₁ receptor expression and secretory function in an INS-1E beta-cell line

ea0011p273 | Diabetes, metabolism and cardiovascular

Evaluation of Garlic extract effect on serum angiotensin converting enzyme (ACE) level in streptozotocin-diabetic rats

ea0011p274 | Diabetes, metabolism and cardiovascular

Determinants of metabolic syndrome and insulin resistance in hemodialysis patients

ea0011p275 | Diabetes, metabolism and cardiovascular

Hyperlactatidemia caused by acute myocardial infarction in patients with type 2 diabetes mellitus

ea0011p276 | Diabetes, metabolism and cardiovascular

The safety and efficacy of chinese herbal medicine PHS-e2 (Glucoherb) in streptozotocin – induced diabetic wistar rats

ea0011p277 | Diabetes, metabolism and cardiovascular

Education for diabetic patients for fasting of Ramadan: a questionnaire study

ea0011p278 | Diabetes, metabolism and cardiovascular

Alcohol intake deteriorates insulin receptors and adipokines expression in rat adipose tissue

ea0011p279 | Diabetes, metabolism and cardiovascular

Des-acyl ghrelin regulates glucose and lipid metabolism in HL-1 cardiomyocytes

ea0011p280 | Diabetes, metabolism and cardiovascular

Regulation of brain-derived resistin and FIAF in a novel hypothalamic neuronal cell line

ea0011p281 | Diabetes, metabolism and cardiovascular

Myocardial ischemia in type 1 diabetic patients – re-examination after four years

ea0011p282 | Diabetes, metabolism and cardiovascular

The metabolic syndroma presence in peripheral arterial occlusive disease of diabetic patients

ea0011p283 | Diabetes, metabolism and cardiovascular

A TCF1 mutation may cause transient congenital hyperinsulinism followed by MODY3

ea0011p284 | Diabetes, metabolism and cardiovascular

Waist circumference cut-offs for categorisation among Tunisian adult population

ea0011p285 | Diabetes, metabolism and cardiovascular

Associations between bmi and smoking with reference to other life style factors, the 4th and the 5th Tromsø studies

ea0011p286 | Diabetes, metabolism and cardiovascular

Gene variants at calpain-5 locus are associated with obesity and other features of metabolic syndrome

ea0011p287 | Diabetes, metabolism and cardiovascular

Plasma concentrations of asymmetric dimethyl arginine and total homocysteine in siblings of type 2 diabetes mellitus

ea0011p288 | Diabetes, metabolism and cardiovascular

Mortality risks of diabetic patients who reach end stage renal disease (ESRD) in the united states: age and gender differences

ea0011p289 | Diabetes, metabolism and cardiovascular

Hormonal profile in men suffering from coronary artery disease and metabolic syndrome

ea0011p290 | Diabetes, metabolism and cardiovascular

The impact of vitamins and/or minerals supplementation on blood pressure in type 2 diabetes

ea0011p291 | Diabetes, metabolism and cardiovascular

Pro12Ala PPAR gamma2 gene polymorphism in PCOS women - the role of the satiety and insulin activity regulating compounds

ea0011p292 | Diabetes, metabolism and cardiovascular

Glucose metabolism, insulin secretion and insulin sensitivity in juvenile hemochromatosis

ea0011p293 | Diabetes, metabolism and cardiovascular

Glucocorticoids are metabolised within perivascular adipose: the link between metabolic diseases and their vascular consequences?

ea0011p294 | Diabetes, metabolism and cardiovascular

Absence of sexual dimorphism in the symptomatic responses to hypoglycaemia in adults with and without type 1 diabetes

ea0011p295 | Diabetes, metabolism and cardiovascular

Metabolic syndrome and insulin sensitivity in early glycoregulation disorders

ea0011p296 | Diabetes, metabolism and cardiovascular

Biochemical predictors of the cardiovascular complications in patients with obesity and type 2 diabetes

ea0011p297 | Diabetes, metabolism and cardiovascular

Decreased cardiac and arterial noradrenaline and dopamine concentrations occur concomitantly with the development of type II diabetes in rats treated neonatally with monosodium glutamate (MSG): a possible basis for autonomic neuropathy?

ea0011p298 | Diabetes, metabolism and cardiovascular

Gender distribution in Ukrainian adult insulin-treated diabetics depending of age at diagnosis

ea0011p299 | Diabetes, metabolism and cardiovascular

Effects of arm exercise on metabolic parameters in type 2 diabetic patients

ea0011p300 | Diabetes, metabolism and cardiovascular

The ethanolic extract of Combretum decandrum Roxb. improved glucose tolerance and increased glucose uptake of hyperinsulinemic rats

ea0011p301 | Diabetes, metabolism and cardiovascular

In-patients food intake and reasons of non-consumption

ea0011p302 | Diabetes, metabolism and cardiovascular

Renal expression of alpha-ENaC is increased in testosterone treated rats

ea0011p303 | Diabetes, metabolism and cardiovascular

Insulin resistance syndrome (IRS) and non-alcoholic fatty liver disease (NAFLD) in obese children: influence of ethnic background, sex, age and family history of type 2 diabetes (T2DM)

ea0011p304 | Diabetes, metabolism and cardiovascular

Serum ghrelin levels during oral glucose challenge – new insights from gastrectomized patients

ea0011p305 | Diabetes, metabolism and cardiovascular

A gene gene interaction of single nucleotide polymorphisms within two oxidative stress genes affects arterial compliance in patients with coronary artery disease

ea0011p306 | Diabetes, metabolism and cardiovascular

The variable number of tandem repeat polymorphism in the NOS3 gene is associated with arterial compliance and insulin resistance in coronary artery disease

ea0011p307 | Diabetes, metabolism and cardiovascular

Altered cholesterol and bile acid homeostasis in the hexose-6-phosphate dehydrogenase (H6PDH) knockout mouse

ea0011p308 | Diabetes, metabolism and cardiovascular

Insulin secretion in HBV and HCV infected patients with type 2 diabetes mellitus

ea0011p309 | Diabetes, metabolism and cardiovascular

The pancreatic beta-cells autoantibodies in HBV and HCV infested patients with type 2 diabetes mellitus

ea0011p310 | Diabetes, metabolism and cardiovascular

Adrenomedullin increases the expression of CLR and RAMP2 in microvascular endothelial cells

ea0011p311 | Diabetes, metabolism and cardiovascular

Sympathetic function in carriers of MC4R mutations

ea0011p312 | Diabetes, metabolism and cardiovascular

A case of myocardial infarction induced by factitious hypoglycaemia in type 2 diabetes patient

ea0011p313 | Diabetes, metabolism and cardiovascular

Orlistat improves postprandial triglyceride metabolism in obese patients with or without diabetes

ea0011p314 | Diabetes, metabolism and cardiovascular

Challenge in Achieving Target Hba1c in a relatively rare Diabetes complication

ea0011p315 | Diabetes, metabolism and cardiovascular

Depot specific activation of inflammatory signalling molecules JNK and NFκB in human abdominal subcutaneous and omental adipose tissue

ea0011p316 | Diabetes, metabolism and cardiovascular

Endothelial, inflammatory and endocrine markers in women with PCOS before and after metformin treatment

ea0011p317 | Diabetes, metabolism and cardiovascular

Expression and regulation of adiponectin receptors (AdR-1 and AdR-2) in pancreatic beta-cells

ea0011p318 | Diabetes, metabolism and cardiovascular

Cardiovascular risk factors and macrovascular complications in type 2 diabetes

ea0011p319 | Diabetes, metabolism and cardiovascular

Effects of Ezetimibe on serum lipoproteins in patients with homozygous familial hypercholesterolemia undergoing LDL cholesterol apheresis and high dose atorvastatin therapy

ea0011p320 | Diabetes, metabolism and cardiovascular

Effect of micronised fenofibrate on plasma levels of c-reactive protein in combined hyperlipidemia

ea0011p321 | Diabetes, metabolism and cardiovascular

Long term safety of Atorvastatin and Fenofibrate therapy in patients with combined hyperlipidemia

ea0011p322 | Diabetes, metabolism and cardiovascular

Use of insulin glargine during pregnancy in women with type 1 diabetes mellitus

ea0011p323 | Diabetes, metabolism and cardiovascular

Serum ferritin levels and obesity

ea0011p324 | Diabetes, metabolism and cardiovascular

Utility of continuous glucose monitoring (CGMS) to explore glycemic patterns in patients with diabetes mellitus in the UAE

ea0011p325 | Diabetes, metabolism and cardiovascular

Dyslipidemia in premenopausal and postmenopausal obese women

ea0011p326 | Diabetes, metabolism and cardiovascular

The effect of moxonodine on endothelial dysfunction in metabolic syndrome

ea0011p327 | Diabetes, metabolism and cardiovascular

The BsmI and FokI polymorphisms in the vitamin D receptor gene in relation to anthropometric and biochemical parameters describing metabolic syndrome

ea0011p328 | Diabetes, metabolism and cardiovascular

Comparison between NPH insulin and insulin glargine in intensive insulin therapy in type 1 diabetes mellitus

ea0011p329 | Diabetes, metabolism and cardiovascular

Association of c-reactive protein with insulin resistance in first degree relatives of diabetic patients

ea0011p330 | Diabetes, metabolism and cardiovascular

How does glucose insulin potassium improve haemodynamic performance? Evidence for beta-adrenoreceptor and sarcoplasmic reticulum calcium ATPase up-regulation

ea0011p331 | Diabetes, metabolism and cardiovascular

Effects of weight loss on the coronary risk profile in obese patients two years after bariatric surgery

ea0011p332 | Diabetes, metabolism and cardiovascular

The severity of cardiovascular disease in women is modified by estrogen receptor alpha polymorphic variants

ea0011p333 | Diabetes, metabolism and cardiovascular

Adult pancreatic islet progenitor cells exhibit plasticity in vitro

ea0011p334 | Diabetes, metabolism and cardiovascular

Regulation of hexose-6-phosphate dehydrogenase (H6PDH) in human fetal liver WRL-68 cells

ea0011p335 | Diabetes, metabolism and cardiovascular

Relationships between plasma adiponectin and testosterone concentrations in middle-aged men and women

ea0011p336 | Diabetes, metabolism and cardiovascular

Relationship between testosterone and in vivo expression of adipoR1 in skeletal muscle in middle aged Caucasian men

ea0011p337 | Diabetes, metabolism and cardiovascular

Testosterone secretion and melatonin rhythm in men with the metabolic syndrome

ea0011p338 | Diabetes, metabolism and cardiovascular

Mortality and morbidity are objective epidemiological indices that reflect state of diabetic aid in region

ea0011p339 | Diabetes, metabolism and cardiovascular

Prevalence of diabetic foot syndrome among diabetes patients

ea0011p340 | Diabetes, metabolism and cardiovascular

Decreased cutaneous vasomotor responses in patients with insulin resistance

ea0011p341 | Diabetes, metabolism and cardiovascular

Lipid profile in normal weight and obese women with polycystic ovary syndrome

ea0011p342 | Diabetes, metabolism and cardiovascular

Is ghrelin a potential signal of decreased fat-free mass in elderly subjects?

ea0011p343 | Diabetes, metabolism and cardiovascular

Obesity and expression of serotonin transporter (SERT) in human platelets

ea0011p344 | Diabetes, metabolism and cardiovascular

Acute and chronic effect of teriparatide on glucose metabolism in women with established osteoporosis

ea0011p345 | Diabetes, metabolism and cardiovascular

Adipose glucocorticoid synthesis: transcription of the 11β-hydroxylase gene in omental but not subcutaneous adipose tissue

ea0011p346 | Diabetes, metabolism and cardiovascular

Metabolic syndrome among patients with primary aldosteronism: a common feature?

ea0011p347 | Diabetes, metabolism and cardiovascular

Metabolic parameters in patients with primary aldosteronism: relation to snps of the adiponectin gene

ea0011p348 | Diabetes, metabolism and cardiovascular

Coronary artery disease and heart failure in diabetic patients in the north of portugal

ea0011p349 | Diabetes, metabolism and cardiovascular

Physiological concentrations of testosterone inhibit extracellular calcium entry via voltage-gated calcium channels in the A7r5 vascular smooth muscle cell line - a non-genomic effect

ea0011p350 | Diabetes, metabolism and cardiovascular

Comparison between premixed insulin aspart 30 vs premixed human insulin 30/70 in combination with metformin in obese type 2 diabetic patients

ea0011p351 | Diabetes, metabolism and cardiovascular

Effect of repaglinide vs glimepirid on glycaemic control in overweight and obese patients with type 2 diabetes mellitus uncontrolled by metformin

ea0011p352 | Diabetes, metabolism and cardiovascular

Association of an insertion/deletion polymorphism in the alpha 2B adrenergic receptor with essential hypertension in diabetic patients

ea0011p353 | Diabetes, metabolism and cardiovascular

The metabolic syndrome and insulin resistance in polycystic ovary syndrome – study over 40 patients

ea0011p354 | Diabetes, metabolism and cardiovascular

Prevalence of registered diabetic nephropathy and its terminal stages

ea0011p356 | Diabetes, metabolism and cardiovascular

Noninsulinoma pancreatogenous hypoglycaemia syndrome (NIPHS) caused by an activating glucokinase mutation

ea0011p357 | Diabetes, metabolism and cardiovascular

Relationship between plasma visfatin levels and the metabolic variables in metabolic syndrome

ea0011p358 | Diabetes, metabolism and cardiovascular

The vasodilatory action of oestrogen in isolated human pulmonary arteries

ea0011p359 | Diabetes, metabolism and cardiovascular

The effect of fluvastatin on adiponectin and insulin sensitivity

ea0011p360 | Diabetes, metabolism and cardiovascular

Leptin as a regulator of serum acylated ghrelin in normal-weight and obese premenopausal women

ea0011p361 | Diabetes, metabolism and cardiovascular

Insulin receptoropathies are distinguished from other syndromes of severe insulin resistance by elevated plasma adiponectin levels

ea0011p362 | Diabetes, metabolism and cardiovascular

Impaired endothelial function in young non-obese women with polycystic ovary syndrome: Normalization with Ethinyl Estradiol-Cyproterone Acetate treatment

ea0011p363 | Diabetes, metabolism and cardiovascular

Carbohydrate metabolism in children with Down syndrome

ea0011p364 | Diabetes, metabolism and cardiovascular

Anti-oxidative effect of 17beta-estradiol in human endothelial cells: the role of Bcl-2

ea0011p365 | Diabetes, metabolism and cardiovascular

Emergence of new addictions following gastric reduction surgery for morbid obesity

ea0011p366 | Diabetes, metabolism and cardiovascular

Is there male androgenetic alopecia the sign of male equivalent of polycystic ovary syndrome or metabolic syndrome?

ea0011p367 | Diabetes, metabolism and cardiovascular

Increased prevalence of the metabolic syndrome by NCEP, WHO and IDF criteria in women with PCOS

ea0011p368 | Diabetes, metabolism and cardiovascular

Estrogen receptor alpha (ER ‘alpha’) gene polymorphisms and first-ever primary intracerebral hemorrhage (PICH)

ea0011p369 | Diabetes, metabolism and cardiovascular

The metabolic control levels of 548 diabetic outpatients compared with the current guidelines of Polish Diabetes Association (PDA)

ea0011p370 | Diabetes, metabolism and cardiovascular

Increased sub-clinical inflammation and markers of vascular injury in obese children

ea0011p371 | Diabetes, metabolism and cardiovascular

Clinical, functional and polysomnographics parameters in severely obese patients

ea0011p372 | Diabetes, metabolism and cardiovascular

The role of tumour necrosis factor-alpha in insulin-stimulated endothelial nitric oxide production

ea0011p373 | Diabetes, metabolism and cardiovascular

Correlation of WBC and PLT count with parameters of type 2 diabetes mellitus

ea0011p374 | Diabetes, metabolism and cardiovascular

Field evaluation of a multi-sensor armband in Greek women

ea0011p375 | Diabetes, metabolism and cardiovascular

The acute stimulation of nitric oxide synthesis by rosiglitazone in human aortic endothelial cells is independent of the PPAR gamma receptor but is dependant on the fuel sensing enzyme AMPK

ea0011p376 | Diabetes, metabolism and cardiovascular

Dehydroepiandrosterone in relation to obesity, insulin resistance and lipid spectra in Czech non-diabetic population

ea0011p377 | Diabetes, metabolism and cardiovascular

Frequency of dyslipidemiαs in children – results of lifestyle intervention

ea0011p378 | Diabetes, metabolism and cardiovascular

SiRNA-mediated depletion of synaptotagmin-11 abrogates insulin-stimulated glucose uptake in 3T3-L1 adipocytes

ea0011p379 | Diabetes, metabolism and cardiovascular

Chromosome 1p shows significant linkage to steroid metabolism in hypertension in the British Genetics of Hypertension Study

ea0011p380 | Diabetes, metabolism and cardiovascular

Impaired glucose metabolism in patients with Cushing’s Syndrome

ea0011p381 | Diabetes, metabolism and cardiovascular

Effects of bariatric surgery on preclinical myocardial alterations in severe obesity and the related role of insulin resistance

ea0011p382 | Diabetes, metabolism and cardiovascular

The effect of an 18 week group exercise education program on weight, physical activity, cardiovascular fitness, quality of life and attitudes to exercise in obese irish female adults

ea0011p383 | Diabetes, metabolism and cardiovascular

Direct effect of cannabinoids and ghrelin on liver and adipose cell metabolism via the AMP-activated protein kinase (AMPK) enzyme

ea0011p384 | Diabetes, metabolism and cardiovascular

Expression and Localisation of human tissue kallikrein in transfected human embryonic kidney cells (HEK-293). Development of a novel panel of monoclonal antibodies (mAbs) against human tissue kallikrein

ea0011p385 | Diabetes, metabolism and cardiovascular

Dietary regulation of peripheral glucocorticoid action: comparison of saturated and unsaturated fats

ea0011p386 | Diabetes, metabolism and cardiovascular

The KCNJ11 E23K and UCP2 G-866A SNPs in relation to DM2 in Czech population

ea0011p387 | Diabetes, metabolism and cardiovascular

Androgen regulation of hepatic glucocorticoid metabolism in obese Zucker rats

ea0011p388 | Diabetes, metabolism and cardiovascular

Plasma N-terminal pro-brain natriuretic peptide and adiponectin levels increases during weight loss

ea0011p389 | Diabetes, metabolism and cardiovascular

Multiple signalling pathways are involved in the phosphorylation of ERK1/2 upon activation of human OX1R and OX2R: Evidence for differential modulation by orexin-A and orexin-B

ea0011p390 | Diabetes, metabolism and cardiovascular

Association among individual deprivation using the EPICES score and anthropometric factors linked to abdominal and metabolic markers

ea0011p391 | Diabetes, metabolism and cardiovascular

Mapping of adiponectin and adiponectin receptors in the human adult and fetal heart

ea0011p392 | Diabetes, metabolism and cardiovascular

Testosterone replacement therapy reduces insulin resistance, and improves glycaemic control in hypogonadal men with Type 2 diabetes

ea0011p393 | Diabetes, metabolism and cardiovascular

Functional analysis of cardiac orexin receptors: preferential activation by OR-B

ea0011p394 | Diabetes, metabolism and cardiovascular

Orexin receptor expression in human adipose tissue: differential effects of orexins

ea0011p395 | Diabetes, metabolism and cardiovascular

Insulin sensitivity and lipid profile in obese and normal weight hypertensive subjects

ea0011p396 | Diabetes, metabolism and cardiovascular

Human adipocytes attenuate cardiomyocyte contraction. A direct link between heart failure and obesity

ea0011p397 | Diabetes, metabolism and cardiovascular

Dietary potassium driven responses in the renal WNK kinase pathway in vivo

ea0011p398 | Diabetes, metabolism and cardiovascular

The in vitro and in vivo role of diabetic status and insulin sensitisers on the novel adipocytokine, visfatin

ea0011p399 | Diabetes, metabolism and cardiovascular

Adrenocortical function in obese Zucker rats

ea0011p400 | Diabetes, metabolism and cardiovascular

Recurrence rate of atrial fibrillation in amiodarone-induced hyperthyroidism

ea0011p401 | Diabetes, metabolism and cardiovascular

The effect of hyperthyroidia on glycemic control in patients with diabetes mellitus

ea0011p402 | Diabetes, metabolism and cardiovascular

Flow mediated dilatation and svcam concentration as the markers of endothelial dysfunction in patients with acromegaly

ea0011p403 | Diabetes, metabolism and cardiovascular

Low endogenous testosterone induces fatty streak formation following cholesterol feeding in the testosterone deficient testicular feminised mouse and castrated male

ea0011p404 | Diabetes, metabolism and cardiovascular

Testosterone replacement reduces aortic fatty streak formation in testosterone deficient Tfm mice following feeding on a cholesterol-enriched diet

ea0011p405 | Diabetes, metabolism and cardiovascular

Growth hormone and IGFBP-3 but not IGF-1 are independent predictors for insulin sensitivity in healthy subjects: on the role of hGH in the metabolic syndrome

ea0011p406 | Diabetes, metabolism and cardiovascular

Dehydroepiandrosterone inhibits differentiation, proliferation and 11β-hydroxysteroid dehydrogenase type 1 activity in human preadipocytes

ea0011p407 | Diabetes, metabolism and cardiovascular

Urocortin 2 mediates glucose utilization and insulin sensitivity in skeletal muscle

ea0011p408 | Diabetes, metabolism and cardiovascular

Elevated serum hs-CRP in the obese – still much to be explained

ea0011p409 | Diabetes, metabolism and cardiovascular

Lipoprotein Lp(a) in patients with systemic lupus erythematosus

ea0011p410 | Diabetes, metabolism and cardiovascular

Effects of alcoholic extract of walnut (Juglans regia L.) septum on serum lipids and Activities of serum aminotransaminase enzymes in streptozocin-induced diabetic rats

ea0011p411 | Diabetes, metabolism and cardiovascular

The ways in which zinc enters beta cells in the pancreas and the influence of zinc blockers on the development of type 1 diabetes

ea0011p412 | Diabetes, metabolism and cardiovascular

Lipoprotein Lp(a) in patients with rheumatoid arthritis

ea0011p413 | Diabetes, metabolism and cardiovascular

Polymorphisms in insulin-like growth factor binding protein-1 (IGFBP-1) are associated with altered circulating IGF-I and lower body mass index in type-2 diabetes mellitus

ea0011p414 | Diabetes, metabolism and cardiovascular

Polymorphisms in insulin-like growth factor binding protein-1 (IGFBP-1) are associated with increased type-2 diabetes mellitus prevalence

ea0011p415 | Diabetes, metabolism and cardiovascular

Cardiac autonomic neuropathy in relation to some components of metabolic syndrome in newly diagnosed type 2 diabetic patients

ea0011p416 | Diabetes, metabolism and cardiovascular

Severity of depression in patients with type 1 and type 2 diabetes and its relation to the level of glycemia control and anti-depressive therapy

ea0011p417 | Diabetes, metabolism and cardiovascular

Cardiac autonomic and peripheral neuropathy in newly diagnosed type 2 diabetic patients

ea0011p418 | Diabetes, metabolism and cardiovascular

Rapid effect of repaglinide in combination with metformin in poorly controlled obese patients with type 2 diabetes mellitus

ea0011p419 | Diabetes, metabolism and cardiovascular

Impact of migration on circulating adipocytokines in an Asian Indian population

ea0011p420 | Diabetes, metabolism and cardiovascular

Migration to the UK results in significantly lower testosterone levels in South Asian men

ea0011p421 | Diabetes, metabolism and cardiovascular

Prevalence of skin manifestations in diabetics

ea0011p422 | Diabetes, metabolism and cardiovascular

Correlations between leptin, insulin resistance and lipid profile in postmenopausal women

ea0011p423 | Diabetes, metabolism and cardiovascular

Correlation between glycemia levels and mortality rate in patients with type 2 diabetes and prior myocardial infarction

ea0011p424 | Diabetes, metabolism and cardiovascular

Left ventricular geometry and contractile ability in type 2 diabetes and non-diabetic patients with mild hypertension

ea0011p425 | Diabetes, metabolism and cardiovascular

Effect of lacidipine on left ventricular mass and blood pressure circadian rhythm in hypertensive diabetic patients

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

Biosci Abstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more